Speakers

 

 

Luiza Abdo, Doctor, Brazilian National Cancer Institute

Luiza Abdo | Doctor | Brazilian National Cancer Institute » speaking at Advanced Therapies USA

James Adams, Chief Technical Officer, Tr1x, Inc

James Adams | Chief Technical Officer | Tr1x, Inc » speaking at Advanced Therapies USA

Faizzan Ahmad, Chief Executive Officer, Cure8bio

Faizzan Ahmad | Chief Executive Officer | Cure8bio » speaking at Advanced Therapies USA

Pavel Aprelev, Director of Corporate Development, Verismo Therapeutics

Pavel Aprelev | Director of Corporate Development | Verismo Therapeutics » speaking at Advanced Therapies USA

Jared Auclair, Director of Bioinnovation, Northeastern University

Jared Auclair | Director of Bioinnovation | Northeastern University » speaking at Advanced Therapies USA

Daniel Baker, PhD Candidate, June Lab, University of Pennsylvania School Of Medicine

Daniel Baker | PhD Candidate, June Lab | University of Pennsylvania School Of Medicine » speaking at Advanced Therapies USA

Christopher Ballas, Chief Technology Officer, Castle Creek Biosciences

Christopher Ballas | Chief Technology Officer | Castle Creek Biosciences » speaking at Advanced Therapies USA

Cecile Bauche, Chief Scientific Officer, Alaya.bio

Cecile Bauche | Chief Scientific Officer | Alaya.bio » speaking at Advanced Therapies USA

Alexandra Beumer Sassi, Executive Director, CMC Regulatory Affairs, AstraZeneca

Alexandra Beumer Sassi | Executive Director, CMC Regulatory Affairs | AstraZeneca » speaking at Advanced Therapies USA

Gwendolyn Binder, President of Science and Technology, Cabaletta Bio

Gwendolyn Binder | President of Science and Technology | Cabaletta Bio » speaking at Advanced Therapies USA

Petter Bjorquist, CEO, VERIGRAFT AB

Petter Bjorquist | CEO | VERIGRAFT AB » speaking at Advanced Therapies USA

Jaap Jan Boelens, Chief, Transplantation and Cellular Therapies, Memorial Sloan-Kettering Cancer Center

Jaap Jan Boelens | Chief, Transplantation and Cellular Therapies | Memorial Sloan-Kettering Cancer Center » speaking at Advanced Therapies USA

Martin Bonamino, Head of Cell and Gene Therapy Program, National Cancer Institute of Brazil

Martin Bonamino | Head of Cell and Gene Therapy Program | National Cancer Institute of Brazil » speaking at Advanced Therapies USA

Anne Brooks, Senior Vice President, US Commercial, Iovance Biotherapeutics

Anne Brooks | Senior Vice President, US Commercial | Iovance Biotherapeutics » speaking at Advanced Therapies USA

Frederic Bushman, Professor and Chair, Department of Microbiology, Co-Director PennCHOP Microbiome Program, Perelman School of Medicine at the University of Pennsylvania

Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics

Omer Butt | Vice President, Regulatory Affairs | CytoImmune Therapeutics » speaking at Advanced Therapies USA

Pedro Cejas, Head of New Therapeutic Modalities, Spark Therapeutics

Pedro Cejas | Head of New Therapeutic Modalities | Spark Therapeutics » speaking at Advanced Therapies USA

Caralynn Collens, CEO, Dimension Inx

Caralynn Collens | CEO | Dimension Inx » speaking at Advanced Therapies USA

Angela Columbano, Head Business Development Partnership, Genethon

Angela Columbano | Head Business Development Partnership | Genethon » speaking at Advanced Therapies USA

Amanda Conerty, Executive Director of Process, Analytical Development and Manufacturing, Artiva Biotherapeutics

Amanda Conerty | Executive Director of Process, Analytical Development and Manufacturing | Artiva Biotherapeutics » speaking at Advanced Therapies USA

Arun Das, Chief Business Officer, Cabaletta Bio

Arun Das | Chief Business Officer | Cabaletta Bio » speaking at Advanced Therapies USA

Houman Dehghani, Vice President, Technical Development, Cabaletta Bio

Houman Dehghani | Vice President, Technical Development | Cabaletta Bio » speaking at Advanced Therapies USA

Wenjun Di, Senior Scientist, Ultragenyx Pharmaceutical Inc.

Wenjun Di | Senior Scientist | Ultragenyx Pharmaceutical Inc. » speaking at Advanced Therapies USA

Michael DiBiasio-White, Head of Process Development and Manufacturing Innovations-Associate Director, Affinia Therapeutics

Michael DiBiasio-White | Head of Process Development and Manufacturing Innovations-Associate Director | Affinia Therapeutics » speaking at Advanced Therapies USA

Daniel Dornbusch, CEO, Excision Biotherapeutics

Daniel Dornbusch | CEO | Excision Biotherapeutics » speaking at Advanced Therapies USA

Tracy Dowling, Chief Business Officer and General Counsel, Asklepios BioPharmaceutical Inc

Tracy Dowling | Chief Business Officer and General Counsel | Asklepios BioPharmaceutical Inc » speaking at Advanced Therapies USA

Mark Duckworth, Sr. Director Cellular and Gene Therapy Operations, Children's Hospital of Philadelphia

Mark Duckworth | Sr. Director Cellular and Gene Therapy Operations | Children's Hospital of Philadelphia » speaking at Advanced Therapies USA

Mark Dudley, Chief Scientific Officer, Instil Bio

Mark Dudley | Chief Scientific Officer | Instil Bio » speaking at Advanced Therapies USA

Jakob Dupont, Executive Partner, Sofinnova Investments

Kate Excoffon, VP Research, Spirovant Sciences Inc.

Miguel Forte, CEO, Kiji Tx

Miguel Forte | CEO | Kiji Tx » speaking at Advanced Therapies USA

Nelson Freeburg, Post-doc Researcher, University of Pennsylvania

Patrick Gailliot, Sr. Director, Patient Operations, Abeona Therapeutics

Anthony Garcia, Head of Quality Control, Kiromic Biopharma Inc

Anthony Garcia | Head of Quality Control | Kiromic Biopharma Inc » speaking at Advanced Therapies USA

Maurits Geerlings, President & CEO, NanoCell Therapeutics

Maurits Geerlings | President & CEO | NanoCell Therapeutics » speaking at Advanced Therapies USA

David Geoghegan, SVP, Head of Quality and Validation, Spark Therapeutics

David Geoghegan | SVP, Head of Quality and Validation | Spark Therapeutics » speaking at Advanced Therapies USA

Mahnoor Gondal, PhD Candidate, University of Michigan

Mahnoor Gondal | PhD Candidate | University of Michigan » speaking at Advanced Therapies USA

Shon Green, VP, Nonclinical Development, Adicet Bio

Shon Green | VP, Nonclinical Development | Adicet Bio » speaking at Advanced Therapies USA

Dave Greenwald, Vice President Of Business Development, Deerfield Management

Dave Greenwald | Vice President Of Business Development | Deerfield Management » speaking at Advanced Therapies USA

Michael Guerrero, Vice President of Technical Development and Operations, BridgeBio

Michael Guerrero | Vice President of Technical Development and Operations | BridgeBio » speaking at Advanced Therapies USA

Xuecui Guo, Director of Gene Regulation, MeiraGTx

Xuecui Guo | Director of Gene Regulation | MeiraGTx » speaking at Advanced Therapies USA

Eric Hacherl, Chief Operating Officer, Kyttaro Therapeutics

Eric Hacherl | Chief Operating Officer | Kyttaro Therapeutics » speaking at Advanced Therapies USA

Heather Harte-Hall, Chief Compliance Officer, Cabaletta Bio

Heather Harte-Hall | Chief Compliance Officer | Cabaletta Bio » speaking at Advanced Therapies USA

Craig Hasilo, Chief Scientific Officer, Canadian Advanced Therapies Training Institute

Craig Hasilo | Chief Scientific Officer | Canadian Advanced Therapies Training Institute » speaking at Advanced Therapies USA

Friederike Herbst-Nowrouzi, Director of the Human Genome Editing Laboratory (HGEL), Perelman School of Medicine University of Pennsylvania

Friederike Herbst-Nowrouzi | Director of the Human Genome Editing Laboratory (HGEL) | Perelman School of Medicine University of Pennsylvania » speaking at Advanced Therapies USA

Steven Highfill, Director of Product Development, Center for Cellular Engineering, Clinical Center, National Institutes of Health

Steven Highfill | Director of Product Development, Center for Cellular Engineering, Clinical Center | National Institutes of Health » speaking at Advanced Therapies USA

Amy House, Head of Portfolio Strategy, Beacon Therapeutics

Amy House | Head of Portfolio Strategy | Beacon Therapeutics » speaking at Advanced Therapies USA

Kathryn Ivey, Senior Vice President of Research, Tenaya Therapeutics

Kathryn Ivey | Senior Vice President of Research | Tenaya Therapeutics » speaking at Advanced Therapies USA

Kaiyuan Jiang, Associate Director, API Cell Therapy, Johnson and Johnson Innovative Medicine

Kaiyuan Jiang | Associate Director, API Cell Therapy | Johnson and Johnson Innovative Medicine » speaking at Advanced Therapies USA

Quan Jin, Capsid Engineering Lead, Spark Therapeutics

Quan Jin | Capsid Engineering Lead | Spark Therapeutics » speaking at Advanced Therapies USA

Mi Jin, Head of Drug Substance, Spark Therapeutics

Mi Jin | Head of Drug Substance | Spark Therapeutics » speaking at Advanced Therapies USA

Rita Johnson-Greene, Chief Operating Officer, Alliance for Regenerative Medicine

Rita Johnson-Greene | Chief Operating Officer | Alliance for Regenerative Medicine » speaking at Advanced Therapies USA

Micheala Jones, Lead, Global Medical Affairs, Hemophilia Gene Editing (CRISPR/Cas9) and Thrombosis, Regeneron

Micheala Jones | Lead, Global Medical Affairs, Hemophilia Gene Editing (CRISPR/Cas9) and Thrombosis | Regeneron » speaking at Advanced Therapies USA

Margareth Jorvid, Head of Regulatory Affairs, Ilya Pharma

Margareth Jorvid | Head of Regulatory Affairs | Ilya Pharma » speaking at Advanced Therapies USA

Angela Justice, Chief People Officer / Executive Advisor, Justice Group Advisors

Angela Justice | Chief People Officer / Executive Advisor | Justice Group Advisors » speaking at Advanced Therapies USA

Stephan Kadauke, Associate Professor of Clinical Pathology and Lab Medicine, The Children's Hospital of Philadelphia

Stephan Kadauke | Associate Professor of Clinical Pathology and Lab Medicine | The Children's Hospital of Philadelphia » speaking at Advanced Therapies USA

Lisa Kahlman, Executive Director, Public Policy & Public affairs, Ultragenyx Pharmaceutical Inc.

Lisa Kahlman | Executive Director, Public Policy & Public affairs | Ultragenyx Pharmaceutical Inc. » speaking at Advanced Therapies USA

Hemachandran Kannan, Director - AI Research Centre, Woxsen University

Hemachandran Kannan | Director - AI Research Centre | Woxsen University » speaking at Advanced Therapies USA

William Kearns, Chief Executive Officer and CSO, Genzeva

William Kearns | Chief Executive Officer and CSO | Genzeva » speaking at Advanced Therapies USA

Saad Kenderian, Co Leader, Cancer Immunology and Immunotherapy, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic

Saad Kenderian | Co Leader, Cancer Immunology and Immunotherapy, Mayo Clinic Comprehensive Cancer Center | Mayo Clinic » speaking at Advanced Therapies USA

Daniel KIlbank, CSO, Mygogenesis LLC

Daniel KIlbank | CSO | Mygogenesis LLC » speaking at Advanced Therapies USA

Matt Killeen, President, TikkunLev Therapeutics

Matt Killeen | President | TikkunLev Therapeutics » speaking at Advanced Therapies USA

Michael Klichinsky, Co-Founder, Vice President Of Discovery And Research, Carisma Therapeutics

Michael Klichinsky | Co-Founder, Vice President Of Discovery And Research | Carisma Therapeutics » speaking at Advanced Therapies USA

Eric Kmiec, Founder & CEO, CorriXR Therapeutics

Eric Kmiec | Founder & CEO | CorriXR Therapeutics » speaking at Advanced Therapies USA

Roland Kolbeck, Chief Scientific Officer, Spirovant Sciences

Roland Kolbeck | Chief Scientific Officer | Spirovant Sciences » speaking at Advanced Therapies USA

Brett Kopelan. MA, Executive Director, DebRa of America

Brett Kopelan. MA | Executive Director | DebRa of America » speaking at Advanced Therapies USA

Nidhi Kotecha, Program Director, Regulatory Affairs, Gates Institute

Nidhi Kotecha | Program Director, Regulatory Affairs | Gates Institute » speaking at Advanced Therapies USA

Kat Kozyrytska, Consultant, Consultant

Kat Kozyrytska | Consultant | Consultant » speaking at Advanced Therapies USA

Ashley Krull, Associate Director, Cell Therapy Manufacturing and Engineering, The Ohio State University Wexner Medical Center

Ashley Krull | Associate Director, Cell Therapy Manufacturing and Engineering | The Ohio State University Wexner Medical Center » speaking at Advanced Therapies USA

Joanne Kurtzberg, Director, Marcus Center For Cellular Cures,, Duke University Medical Center

Joanne Kurtzberg | Director, Marcus Center For Cellular Cures, | Duke University Medical Center » speaking at Advanced Therapies USA

Simon Lacey, Vice President - Immunology, Asklepios BioPharmaceutical, Inc. (AskBio)

Simon Lacey | Vice President - Immunology | Asklepios BioPharmaceutical, Inc. (AskBio) » speaking at Advanced Therapies USA

Michael Lehmicke, Sr. Vice President, Science & Industry Affairs, Alliance for Regenerative Medicine

Michael Lehmicke | Sr. Vice President, Science & Industry Affairs | Alliance for Regenerative Medicine » speaking at Advanced Therapies USA

Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, Perelman School of Medicine University of Pennsylvania

Bruce Levine | Barbara and Edward Netter Professor in Cancer Gene Therapy | Perelman School of Medicine University of Pennsylvania » speaking at Advanced Therapies USA

Yan Li, Senior Director, Process Development, Cabaletta Bio

Yan Li | Senior Director, Process Development | Cabaletta Bio » speaking at Advanced Therapies USA

Kirstin Liechty, Sr. Director, Clinical Operations, A2 Biotherapeutics Inc

Kirstin Liechty | Sr. Director, Clinical Operations | A2 Biotherapeutics Inc » speaking at Advanced Therapies USA

Hernando Lopez-Bertoni, Associate Professor, Johns Hopkins Medicine

Hernando Lopez-Bertoni | Associate Professor | Johns Hopkins Medicine » speaking at Advanced Therapies USA

Raymond Luke, Director, MSAT, Verismo Therapeutics

Raymond Luke | Director, MSAT | Verismo Therapeutics » speaking at Advanced Therapies USA

Deepu Madduri, Senior Director, Compound Development Team Lead, CARVYKTI, Johnson & Johnson

Deepu Madduri | Senior Director, Compound Development Team Lead, CARVYKTI | Johnson & Johnson » speaking at Advanced Therapies USA

Martin Maiers, VP, Research, NMDP

Martin Maiers | VP, Research | NMDP » speaking at Advanced Therapies USA

Stephanie Maistrellis, CEO, Lead Life Sciences

Stephanie Maistrellis | CEO | Lead Life Sciences » speaking at Advanced Therapies USA

Kimberly Malecka, Senior Scientist, Spark Therapeutics

Kimberly Malecka | Senior Scientist | Spark Therapeutics » speaking at Advanced Therapies USA

Craig Martin, Founder, CEO, Orphan Therapeutics Accelerator

Craig Martin | Founder, CEO | Orphan Therapeutics Accelerator » speaking at Advanced Therapies USA

Melissa Maxwell, Director of Research and Program Management, Phio Pharmaceuticals Corp.

Michael Mehler, Director, Cell Therapy Patient Operations, AstraZeneca

Michael Mehler | Director, Cell Therapy Patient Operations | AstraZeneca » speaking at Advanced Therapies USA

Fiona Miller, Managing Partner, quadraScope Ventures

Fiona Miller | Managing Partner | quadraScope Ventures » speaking at Advanced Therapies USA

Dara Missan, Staff Scientist, Process Development, Mayo Clinic

Dara Missan | Staff Scientist, Process Development | Mayo Clinic » speaking at Advanced Therapies USA

Samarendra Mohanty, Founder-President, Chief Scientific Officer, Nanoscope Therapeutics

Samarendra Mohanty | Founder-President, Chief Scientific Officer | Nanoscope Therapeutics » speaking at Advanced Therapies USA

David Morrow, Senior scientific manager, EATRIS

David Morrow | Senior scientific manager | EATRIS » speaking at Advanced Therapies USA

Snehal Naik, Head of Regulatory Policy; Strategy Leader (Ocular), Spark Therapeutics

Snehal Naik | Head of Regulatory Policy; Strategy Leader (Ocular) | Spark Therapeutics » speaking at Advanced Therapies USA

Prachi Narayan, Global QC Stability Lead, Iovance Biotherapeutics

Prachi Narayan | Global QC Stability Lead | Iovance Biotherapeutics » speaking at Advanced Therapies USA

Kimberly Neff, Founder/Director, Herpes Cure Advocacy

Kimberly Neff | Founder/Director | Herpes Cure Advocacy » speaking at Advanced Therapies USA

Cokey Nguyen, President and CEO, Atara Biotherapeutics

Cokey Nguyen | President and CEO | Atara Biotherapeutics » speaking at Advanced Therapies USA

Sean O'Brien, Senior Scientist, AstraZeneca

Sean O'Brien | Senior Scientist | AstraZeneca » speaking at Advanced Therapies USA

Raphael Ognar, President & Chief Executive Officer, Co-Founder, NKILT Therapeutics Inc.

Daniel Oliver, Chief Executive Officer And Founder, Rejuvenate Bio

Daniel Oliver | Chief Executive Officer And Founder | Rejuvenate Bio » speaking at Advanced Therapies USA

Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)

Nneka Onwudiwe | Former PRO/PE Regulatory Review Officer | Food and Drug Administration (FDA) » speaking at Advanced Therapies USA

Kathleen O'Sullivan-Fortin, General Counsel, A.L.D. Connect

Kathleen O'Sullivan-Fortin | General Counsel | A.L.D. Connect » speaking at Advanced Therapies USA

Amy Pagliarulo, Senior Director Director of ATC Cell Therapy Operations, Iovance Biotherapeutics

Amy Pagliarulo | Senior Director Director of ATC Cell Therapy Operations | Iovance Biotherapeutics » speaking at Advanced Therapies USA

Parimal Pande, Associate Scientific Director, Johnson & Johnson

Parimal Pande | Associate Scientific Director | Johnson & Johnson » speaking at Advanced Therapies USA

Melissa Penn, Director Patient Engagement Research & Development, Bayer

Melissa Penn | Director Patient Engagement Research & Development | Bayer » speaking at Advanced Therapies USA

David Peritt, Chief Scientific Officer, Lupagen

David Peritt | Chief Scientific Officer | Lupagen » speaking at Advanced Therapies USA

Vicki Plaks, Senior Scientific Director and Head of Cell Therapy, Oncology Translational Research, Johnson & Johnson

Vicki Plaks | Senior Scientific Director and Head of Cell Therapy, Oncology Translational Research | Johnson & Johnson » speaking at Advanced Therapies USA

Nolan Polson, VP Quality Assurance and Product Quality, Iovance Biotherapeutics

Nolan Polson | VP Quality Assurance and Product Quality | Iovance Biotherapeutics » speaking at Advanced Therapies USA

David Porter, Director, Cell Therapy and Transplant, University of Pennsylvania

David Porter | Director, Cell Therapy and Transplant | University of Pennsylvania » speaking at Advanced Therapies USA

Brian Price, Chief Technology Officer, Armatus Bio, Inc

Brian Price | Chief Technology Officer | Armatus Bio, Inc » speaking at Advanced Therapies USA

Huma Qamar, Chief Medical Officer, Ocugen

Huma Qamar | Chief Medical Officer | Ocugen » speaking at Advanced Therapies USA

Xi Qin, Co-CEO, NeuExcell Therapeutics

Wenchun Qu, Associate Director of Centre for Regenerative Bio therapeutics in Florida, Mayo Clinic

Wenchun Qu | Associate Director of Centre for Regenerative Bio therapeutics in Florida | Mayo Clinic » speaking at Advanced Therapies USA

Shahrooz Rabizadeh, CEO & Co-Founder, Sagittarius Bio, Inc

Shahrooz Rabizadeh | CEO & Co-Founder | Sagittarius Bio, Inc » speaking at Advanced Therapies USA

Jack Ragheb, Former Chief Medical Research Officer, FDA

Jack Ragheb | Former Chief Medical Research Officer | FDA » speaking at Advanced Therapies USA

Lior Raviv, CTO, Pluri

Lior Raviv | CTO | Pluri » speaking at Advanced Therapies USA

Michael Riotto, Patient Advocate, Patient Advocate

Michael Riotto | Patient Advocate | Patient Advocate » speaking at Advanced Therapies USA

Blaine Robinson, Vice President, Therapy Acceleration Program, The Leukemia & Lymphoma Society

Kate Rochlin, Chief Operating Officer, IN8bio

Kate Rochlin | Chief Operating Officer | IN8bio » speaking at Advanced Therapies USA

Qian Ruan, SVP of Technical Operations, Arcturus Therapeutics

Qian Ruan | SVP of Technical Operations | Arcturus Therapeutics » speaking at Advanced Therapies USA

Holger Russ, Associate Professor, University of Florida

Holger Russ | Associate Professor | University of Florida » speaking at Advanced Therapies USA

Arthur Sagoskin, Chief Executive Officer & Co-Founder, Mygogenesis

Arthur Sagoskin | Chief Executive Officer & Co-Founder | Mygogenesis » speaking at Advanced Therapies USA

Jordan Schecter, Vice President | Multiple Myeloma DAS Leader, Johnson and Johnson

Jordan Schecter | Vice President   | Multiple Myeloma DAS Leader | Johnson and Johnson » speaking at Advanced Therapies USA

Jared Schuster, Regulatory Specialist, BioTherapies, NMDP BioTherapies

Jared Schuster | Regulatory Specialist, BioTherapies | NMDP BioTherapies » speaking at Advanced Therapies USA

Vishal Shah, Dean, Division of the Math, Science and Health Careers, Community College of Philadelphia

Vishal Shah | Dean, Division of the Math, Science and Health Careers | Community College of Philadelphia » speaking at Advanced Therapies USA

Nirav Shah, Associate Professor of Medicine, Director, BMT & Cellular Therapy Program, Medical College of Wisconsin

Nirav Shah | Associate Professor of Medicine, Director, BMT & Cellular Therapy Program | Medical College of Wisconsin » speaking at Advanced Therapies USA

Daniel Shelly, Chief Business Development Officer, PolTREG AG

Daniel Shelly | Chief Business Development Officer | PolTREG AG » speaking at Advanced Therapies USA

Dana Silverbush, Assistant Professor of Cancer Biology, University of Pennsylvania

Dana Silverbush | Assistant Professor of Cancer Biology | University of Pennsylvania » speaking at Advanced Therapies USA

Lara Silverman, Principal Consultant, Coeptis and LIS BioConsulting

Lara Silverman | Principal Consultant | Coeptis and LIS BioConsulting » speaking at Advanced Therapies USA

Devyn Smith, Chief Executive Officer, Arbor Biotechnologies

Devyn Smith | Chief Executive Officer | Arbor Biotechnologies » speaking at Advanced Therapies USA

Morten Sogaard, President, Research and Technical Operations, Astellas Gene Therapies

Morten Sogaard | President, Research and Technical Operations | Astellas Gene Therapies » speaking at Advanced Therapies USA

Mike Spencer, Vice President of Oncology Market Access, Johnson & Johnson

Mike Spencer | Vice President of Oncology Market Access | Johnson & Johnson » speaking at Advanced Therapies USA

Antoine Sreih, Vice President, Medical Director, Cullinan Therapeutics, Inc.

Antoine Sreih | Vice President, Medical Director | Cullinan Therapeutics, Inc. » speaking at Advanced Therapies USA

Joseph Stavas, Senior Vice President of Clinical Development, ProKidney

Joseph Stavas | Senior Vice President of Clinical Development | ProKidney » speaking at Advanced Therapies USA

Stephen Sullivan, Director, Lindville Bio

Stephen Sullivan | Director | Lindville Bio » speaking at Advanced Therapies USA

Kris Thiruvillakkat, Sr Director Global Market Access, CSL Behring

Kris Thiruvillakkat | Sr Director Global Market Access | CSL Behring » speaking at Advanced Therapies USA

Sarah Thomas, SVP, Quality, REGENXBIO

Sarah Thomas | SVP, Quality | REGENXBIO » speaking at Advanced Therapies USA

Raisa Uchurova, Scientist, Century Therapeutics

Raisa Uchurova | Scientist | Century Therapeutics » speaking at Advanced Therapies USA

Arun Upadhyay, Chief Scientific Officer, Ocugen

Arun Upadhyay | Chief Scientific Officer | Ocugen » speaking at Advanced Therapies USA

Renaud VAILLANT, CEO & co-Founder, Alaya.bio

Renaud VAILLANT | CEO & co-Founder | Alaya.bio » speaking at Advanced Therapies USA

David Venables, Chief Executive Officer, Laverock Therapeutics

David Venables | Chief Executive Officer | Laverock Therapeutics » speaking at Advanced Therapies USA

Pierre Axel Vinot, Director, CMC Portfolio Management, SparingVision

Pierre Axel Vinot | Director, CMC Portfolio Management | SparingVision » speaking at Advanced Therapies USA

Nelly Viseux, VP, Cell Therapies Development, Manufacturing, Supply & Quality, Regeneron

Nelly Viseux | VP, Cell Therapies Development, Manufacturing,  Supply & Quality | Regeneron » speaking at Advanced Therapies USA

Jim Wang, VP, Global Regulatory Strategy, Genetic Medicines, Regeneron

Jim Wang | VP, Global Regulatory Strategy, Genetic Medicines | Regeneron » speaking at Advanced Therapies USA

Jie Wei, Director, Bioanalytical Sciences, Tr1x, Inc

Jie Wei | Director, Bioanalytical Sciences | Tr1x, Inc » speaking at Advanced Therapies USA

Daniel Weiss, Professor of Medicine, Pulmonary Medicine Department of Medicine, University of Vermont

Daniel Weiss | Professor of Medicine, Pulmonary Medicine Department of Medicine | University of Vermont » speaking at Advanced Therapies USA

Rafal P. Witek, Senior Director of R&D Engineering, Dimension Inx

Rafal P. Witek | Senior Director of R&D Engineering | Dimension Inx » speaking at Advanced Therapies USA

Keith Wonnacott, Vice President Regulatory Affairs, LEXEO Therapeutics

Keith Wonnacott | Vice President Regulatory Affairs | LEXEO Therapeutics » speaking at Advanced Therapies USA

Jeff Wren, Vice President, Biotherapies, AABB

Jeff Wren | Vice President, Biotherapies | AABB » speaking at Advanced Therapies USA

Yuntao Wu, Professor, George Mason University

Yuntao Wu | Professor | George Mason University » speaking at Advanced Therapies USA

Howard Wu, Co-Founder & Chief Scientific Officer, Full Circles Therapeutics

Howard Wu | Co-Founder & Chief Scientific Officer | Full Circles Therapeutics » speaking at Advanced Therapies USA

Guangai Xue, Senior Scientist, Cell Therapy Technical Operations, Global Operations, AstraZeneca

Guangai Xue | Senior Scientist, Cell Therapy Technical Operations, Global Operations | AstraZeneca » speaking at Advanced Therapies USA

Shadan Yarandi, Senior Scientist, Johnson & Johnson Innovative Medicine

Shadan Yarandi | Senior Scientist | Johnson & Johnson Innovative Medicine » speaking at Advanced Therapies USA

Andrew York, Executive Director, Maryland Prescription Drug Affordability Board

Andrew York | Executive Director | Maryland Prescription Drug Affordability Board » speaking at Advanced Therapies USA

Nan Zhang, Chief, Cell Therapy Manufacturing Section, Center for Cellular Engineering, National Institute of Health

Nan Zhang | Chief, Cell Therapy Manufacturing Section, Center for Cellular Engineering | National Institute of Health » speaking at Advanced Therapies USA

Minghong Zhong, CEO, GeneLancet Biosciences, Inc.

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit


Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515


Joshua Lloyd
Josh.Lloyd@terrapinn.com
+44 20 4614 9423

 

To speak


Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604